ABBV vs EGAN · P/E 81, rev $61.16B vs P/E 68, rev $88.4M
AbbVie Inc (ABBV) versus eGain Corporation (EGAN) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
eGain Corporation (EGAN) is a software - application company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported EGAN revenue for 2025-06-30 was $88.4M. Net income was $32.3M. Revenue was up 293.7% from 2024-06-30 to 2025-06-30. EGAN currently screens at market cap $189.3M and trailing P/E 68.0.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. EGAN currently screens at market cap $189.3M and trailing P/E 68.0.
Not investment advice. Open the ABBV and EGAN stock pages for the full models.
Not investment advice.